An immunologically active chimaeric protein containing herpes simplex virus type 1 glycoprotein D.

Abstract

Herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) cause both persistent and latent infections, including recurrent cutaneous disease, lethal neonatal disease, central nervous system disease and other clinical syndromes. Modified live vaccines or conventionally prepared subunit vaccines have generally been unsuccessful in the treatment of HSV-1 and HSV… (More)

Topics

Cite this paper

@article{Weis1983AnIA, title={An immunologically active chimaeric protein containing herpes simplex virus type 1 glycoprotein D.}, author={J. H. Weis and L. W. Enquist and Jennifer Salstrom and R. J. Watson}, journal={Nature}, year={1983}, volume={302 5903}, pages={72-4} }